Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1914 1
1930 1
1932 1
1933 2
1934 1
1935 1
1936 1
1938 1
1943 1
1947 1
1951 1
1953 1
1954 2
1955 1
1956 2
1957 1
1960 1
1971 1
1972 2
1976 1
1985 1
1987 1
1988 1
1989 1
1991 1
1994 1
1995 1
1999 2
2002 1
2003 1
2004 1
2005 3
2006 4
2007 6
2008 3
2009 11
2010 15
2011 13
2012 14
2013 11
2014 31
2015 28
2016 30
2017 28
2018 23
2019 21
2020 23
2021 25
2022 18
2023 16
2024 1

Text availability

Article attribute

Article type

Publication date

Similar articles for PMID: 24595581

316 results

Results by year

Filters applied: . Clear all
Page 1
Comparative efficacy of biologics in psoriasis: a review.
Kim IH, West CE, Kwatra SG, Feldman SR, O'Neill JL. Kim IH, et al. Am J Clin Dermatol. 2012 Dec 1;13(6):365-74. doi: 10.2165/11633110-000000000-00000. Am J Clin Dermatol. 2012. PMID: 22967166 Review.
Efficacy and safety of ixekizumab treatment for Japanese patients with moderate to severe plaque psoriasis, erythrodermic psoriasis and generalized pustular psoriasis: Results from a 52-week, open-label, phase 3 study (UNCOVER-J).
Saeki H, Nakagawa H, Nakajo K, Ishii T, Morisaki Y, Aoki T, Cameron GS, Osuntokun OO; Japanese Ixekizumab Study Group. Saeki H, et al. J Dermatol. 2017 Apr;44(4):355-362. doi: 10.1111/1346-8138.13622. Epub 2016 Oct 11. J Dermatol. 2017. PMID: 27726163 Free PMC article. Clinical Trial.
Biological therapy for pustular psoriasis: a systematic review.
Falto-Aizpurua LA, Martin-Garcia RF, Carrasquillo OY, Nevares-Pomales OW, Sánchez-Flores X, Lorenzo-Rios D. Falto-Aizpurua LA, et al. Int J Dermatol. 2020 Mar;59(3):284-296. doi: 10.1111/ijd.14671. Epub 2019 Oct 15. Int J Dermatol. 2020. PMID: 31612467
Long-term efficacy and safety of ixekizumab in Japanese patients with erythrodermic or generalized pustular psoriasis: subgroup analyses of an open-label, phase 3 study (UNCOVER-J).
Okubo Y, Mabuchi T, Iwatsuki K, Elmaraghy H, Torisu-Itakura H, Morisaki Y, Nakajo K. Okubo Y, et al. J Eur Acad Dermatol Venereol. 2019 Feb;33(2):325-332. doi: 10.1111/jdv.15287. Epub 2018 Nov 15. J Eur Acad Dermatol Venereol. 2019. PMID: 30317671 Free PMC article. Clinical Trial.
Use of biologic agents in pediatric psoriasis.
Marji JS, Marcus R, Moennich J, Mackay-Wiggan J. Marji JS, et al. J Drugs Dermatol. 2010 Aug;9(8):975-86. J Drugs Dermatol. 2010. PMID: 20684148 Review.
316 results